Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

AIM: To assess the efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes (T2D). MATERIALS AND METHODS: This multicentre, double‐blind, parallel‐group study randomized Japanese patients with T2D insufficiently controlled with insulin (1:1:1) to empagliflo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Obes Metab
Main Authors: Sone, Hirohito, Kaneko, Tatsuroh, Shiki, Kosuke, Tachibana, Yoshifumi, Pfarr, Egon, Lee, Jisoo, Tajima, Naoko
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2019
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065067/
https://ncbi.nlm.nih.gov/pubmed/31692244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13909
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki